Search Results 791-800 of 21414 for anti-TNF drugs

  1. Testosterone (Buccal Route) Before Using - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  2. Tbo-Filgrastim (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    When certain cancer medicines are used to fight cancer cells, they also affect the white blood cells that fight infections. Tbo-filgrastim is used to ...

  3. Oatd-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis - Mayo Clinic

    Immunosuppressants or anti-TNF agents (or other antiinflammatory/anti ... Current systemic pharmacological treatment for sarcoidosis or any systemic disease, ...

  4. Calcium Acetate (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Eliphos; PhosLo; Phoslyra. Descriptions.

  5. Prednisone (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Calcipotriene (Topical Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Calcitrene; Dovonex; Sorilux. Descriptions.

  7. Drospirenone And Ethinyl Estradiol (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Gianvi; Loryna; Nikki; Ocella; Syeda ...

  8. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

    Participation eligibility · Subjects who received anticancer therapy or investigational drug within 28 days of first dose. · Subjects who received any approved ...

  9. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

  10. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

    Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary ...